We Offer the Most Advanced Cancer Treatment Technology
Our prostate cancer treatment center offers the most advanced non-surgical technology for radiation treatment of prostate cancer. We embrace cutting-edge technology that allows us to be minimally invasive during treatment while reducing common side effects. When combined with our approach to coordinated care, the technology becomes a critical tool in the treatment of prostate cancer.
For example, RapidArc therapy is the most advanced Intensity Modulated Radiation Treatment or IMRT available for prostate cancer. It allows us to target cancerous tissue with radiation via tightly focused beams, sparing the surrounding healthy tissue and lessening many common side effects.
RapidArc delivers each treatment in approximately 90 seconds, which is up to eight times faster than traditional IMRT. This rapid delivery improves treatment accuracy by minimizing the time that the patient has to hold still and by ensuring that it is completed before there is unintentional motion of the prostate.
In addition, the dose from RapidArc is not delivered in one session. Instead, it is divided into smaller doses that are administered once each weekday for seven to nine weeks, with each visit lasting about 10 to 15 minutes.
We also offer the Calypso targeting and motion control system with every treatment, which acts like a sighting scope for RapidArc, or the equivalent of GPS for the body. It utilizes beacons placed directly in the prostate by your urologist that detect and report any movement of the prostate during the procedure. These non-radioactive beacons use a microwave array to triangulate the position of the prostate in three dimensions, allowing us to aim high energy photons directly at any cancerous tissue. Additionally, ultrasound, bone scans, CT scans, and MRI are all imaging modalities we use at the outset to visualize and diagnose the presence of cancer and to help map out the course of treatment.
Contact us to learn more about our cancer treatment technology. We treat patients in the San Francisco Bay area.